Galectin Therapeutics Investor Relations Material

Galectin Therapeutics Inc. is a biotechnology company that focuses on the development of therapies for fibrotic diseases, cancer, and other conditions related to galectin proteins. The company's research and development efforts are primarily centered on galectin-3, a protein that plays a critical role in various disease processes, including fibrosis and immune response. Galectin Therapeutics aims to create novel treatments that can potentially address unmet medical needs in these areas. The company is headquartered in Norcross, Georgia, and its shares are listed on the NASDAQ.